期刊文献+

运动血压变异性与蛋白尿、动脉硬化的关系 被引量:2

Exercise Blood Pressure Variability,Albuminuria,and Arterial Stiffness in Essential Hypertension
下载PDF
导出
摘要 目的探讨原发性高血压患者运动血压变异性与尿蛋白、动脉硬化的关系。方法 50例健康人,男性女性各半,平均年龄64.5±5.1岁,作为对照组。高血压患者80例,平均年龄65.3±5.7岁,男性女性各半,作为高血压组。分别测运动血压与24h尿蛋白、踝臂动脉脉搏波传导速度(baPWV)。结果高血压组运动血压变异性明显大于对照组(P<0.05)。高血压组的24h尿蛋白含量、baPWV均大于对照组(P<0.05)。运动血压变异性与24h尿蛋白含量、baPWV均正相关(P<0.05)。结论运动血压变异性增大是高血压病的重要特征。运动血压变异性增大易导致动脉硬化及肾功能损害。 Objective To explore the relationship of exercise blood pressure variability with urinary albumin excretion and arterial stiffness in patients with essential hypertension. Methods Fifty normal persons 64.5 ± 5.1 years old were evenly divided by gender as control group. The study group 65.3 ± 5.7 years old consisted of eighty patients with essential hypertension. Exercise blood pressure was measured by treadmill exercise. 24 - hour urine protein was detected with Coomassie brilliant blue method, and arterial stiffness was evaluated on the basis of braehial - ankle pulse wave velocity. Results Patients with essential hypertension exhibited greater urine protein and higher pulse wave velocity and exercise blood pressure variability campared with those with normal pressure. In hypertensive group,excercise blood pressure variability was related to baPWV ( r = 0. 576, P 〈 0.01 ) and 24h - UPRO ( r = 0.510, P 〈 0.01 ). In control group, excercise blood pressure variability was related to baPWV ( r = 0. 423, P 〈 0.01 ) and 24h - U PRO ( r = 0. 376, P 〈 0.05 ). The correlativity of exercise blood pressure variability with baPWV and 24h - UPRO in the hypertensive group was greater than in the control group. Conclusion The increasing variability of exercise blood pressure is an important clinic character in hypertensions,which could induce the decrease of renal function and arterial stiffness at the early stage.
出处 《医学研究杂志》 2012年第4期115-118,共4页 Journal of Medical Research
关键词 运动血压变异性 蛋白尿 动脉硬化 Exercise blood pressure variability Albuminuria Arterial stiffness
  • 相关文献

参考文献12

  • 1Otsuka K, Cornelissen G, Halberg F, et al. Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy[J]. J Med Eng Technol, 1997, 21:23 - 30.
  • 2Veerman DP, De Blok K, van Montfrans A. Relationship of steady state and ambulatory blood pressure variability to left ventricular mass and urinary albumin excretion in essential hypertension[J]. Am J Hypertens, 1996, 9:455 -460.
  • 3Uusitalo AL, Laitinen T, Vaisanen SB. Physical training and heart rate and blood pressure variability: a 5 -yr randomized trial[ J ]. Aln J Physiol Heart Circ Physiol,2004,286(5 ) :H1821 -1826.
  • 4谭静,华琦,闻静,邢绣荣.高血压病患者脉搏波速度与心血管疾病危险因素[J].中华高血压杂志,2007,15(10):807-811. 被引量:42
  • 5Asmar R, Rudnichi A, Blacher J, et al. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations[J]. Am J hypertens, 2001, 14(3) :91 -97.
  • 6Diedrich A, Jordon J, Tank J, et al. The sympathetic nervous system in hypertension:assessment by blood pressure variability and ganglionic blockade[J]. Hypertens,2003 Sep, 21 (9) :1677-1686.
  • 7Julien C. Baroreflex control of sympathetic nerve activity and blood pressure variability[ J ]. Clin Exp Pharmacol Physiol, 2008,35 ( 4 ) : 512 -515.
  • 8Erdogan D, Caliskan M, Yildirim I, et al. Effects of normol blood pressure, prehypertension and hypertension on left vcntricular diastolic function and aortic elastic properties [ J ]. Blood Press,2007, 16 (2) : 114 - 121.
  • 9Mancia G, Parati G, Henning M, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (EISA) [J]. J Hypertens, 2001, 19(11):1981 -1989.
  • 10Tabas I, Williams KJ, Boren J. Subendothelial lipoproteins retention as the initiating process in atherosclerosis: update therapeutic implications [ J ]. Circulation, 2007, 116 ( 16 ) : 1832 - 1844.

二级参考文献32

  • 1魏有仁,侯林浦,王玫,湛玉良,朱立华.尿中微量白蛋白的测定及应用[J].生物化学与生物物理进展,1995,22(2):169-173. 被引量:84
  • 2华琦,谭静,刘东霞,闻静,邢绣荣.高血压病患者颈-股动脉和颈-桡动脉脉搏波速度改变及其影响因素[J].中华心血管病杂志,2005,33(12):1088-1091. 被引量:41
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 4Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? aprospective cohort study of Japanese male workers. J Epidemiol,2000 ,10 :4403-4409.
  • 5Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemias a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis ,2004,44:642-650.
  • 6Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med, 2003,139:137- 147.
  • 7Johnson R J, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 2003, 41 : 1183-1190.
  • 8Amato D, Cleto AA, Rutila CL, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int, 2005, 68:11-17.
  • 9Siu YP, Leung T,Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis, 2006,47:51-59.
  • 10[1]Laurent S,Boutouyrie P,Asmar R,et al.Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients[J].Hypertension,2001,37:1236-1241.

共引文献94

同被引文献30

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部